Identification of Otezla:
No description |
Search images on Google Product Monograph
Active Ingredients:
- apremilast, 30 MG
DIN: 02434334
Dosage Form(s): TABLET
Route(s) of Administration: ORAL
Schedule: Prescription
Company: AMGEN CANADA INC
ATC:
- L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
- L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
- L04AA - Selective immunosuppressants (ATC, WHO)
- L04AA32 - APREMILAST (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 28/56/60